Advancing Buntanetap: Comparative Pharmacokinetic Characterization of the Original Semi‐Crystalline with the Novel Crystalline Form in Animals and Humans

Abstract

Background: Buntanetap is an orally bioavailable small molecule that improves cognitive function in patients with early Alzheimer’s and Parkinson’s diseases. Until now, a semi‐crystalline anhydrate (Form A) has been used in preclinical and clinical studies.

The paper